Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients Sub-Study
NCT04742816Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Sep 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by University of California, San Diego. Primary endpoint: Iohexol clearance at Day 1. Started Sep 2020; status: completed.
Beyond the preview
Go deeper on NCT04742816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742816.